Brief: Harvard Bioscience Announces Third Quarter Results
Nov 5 (Reuters) - Harvard Bioscience Inc HBIO.O :
* HARVARD BIOSCIENCE ANNOUNCES THIRD QUARTER 2020 FINANCIAL
RESULTS
* HARVARD BIOSCIENCE INC QTRLY REVENUE $24 MILLION VERSUS
$27.4
MILLION; QTRLY LOSS PER SHARE $0.03; QTRLY ADJUSTED EPS $0.04
Source text for Eikon: ID:nGNX2Rp7Vw
Further company coverage: HBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harvard Bioscience
See all newsBrief: Harvard Bioscience Announces Creation Of Scientific Advisory Board
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook
Harvard Bioscience Inc expected to post a loss of 21 cents a share - Earnings Preview
Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance